Career arc: CDC → CMS (helped formalize Medicare’s national coverage decision process) → FDA (Director of Professional Affairs & Stakeholder Engagement, CDER) → Discovery Communications → WebMD as Chief Medical Officer, 2018–2025 → AMA. Selected by Board May 9, 2025.
His two signature moves: (1) Eliminated CHE as a standalone Mission BU and merged it with IHO into COHO. (2) Launched the AMA Center for Digital Health and AI Oct 20, 2025 — now leadership-vacant after Lozovatsky’s departure.
His posture: Administration-aligned, not defensive. Hosts CMMI’s Abe Sutton on AMA’s podcast (3 episodes in 4 months). Co-staged with FDA Commissioner Makary at the Feb 2, 2026 Action for Progress launch (hosted by close friend Tom Koutsoumpas, Healthsperien). Modern Healthcare: “AMA CEO seeks to restore the doc group’s lost ‘luster.’”
What changed on July 1, 2025 and June 1, 2026 — and what it means for FHG.
Aletha Maybank, MD, MPH departed end of 2024. CHE eliminated as a standalone Mission BU. Work folded into COHO. The equity pillar lost its named unit and named physician leader.
Jon Giacomin (SVP & COO under Madara) is gone. The COO seat itself was eliminated entirely from the org — not backfilled until Dr. Wig arrives June 1, 2026.
Four pillars: SDOH · Medical Education · Community-Centered Solutions · Data-Driven Research. Programs: Release the Pressure · Medical Justice · Advancing Equity · West Side United · In Full Health · Rise to Health. Seoh elevated to Interim Lead.
New BU: Education Center + AMA Ed Hub™ + PS2 + Strategic Insights. Tutty is SVP running this. Flagship: inaugural Physician Entrepreneur Forum, Aug 7–8, Chicago. Overlaps near-identically with MDEnvoy — the COI story.
Whyte’s signature Lane 3 initiative. Margaret Lozovatsky (CMIO + VP Digital Health) was operational lead — departed to Premier Health May 4, 2026. AI Center is now leadership-vacant mid-build. Open FHG entry path.
Our anchor is now stronger AND higher-altitude. PS2 now sits inside his SVP mandate. He signed MSA AMA 24377 + SOW 17 on AMA’s behalf. Still the named executive of record for dispute escalation under §16.2.
Michael (2026-05-11): “Wozniak and many, many others are gone.” Default assumption: any below-GVP AMA name not refreshed may be a recent departure.
NEW ROLE effective June 1, 2026. Promoted from Group VP to SVP running the new Career Advancement Collective (CAC = Education Center + AMA Ed Hub™ + PS2 + Strategic Insights), reporting directly to CEO Whyte. Credentials: BA Government (Western New England College) · MHA (Clark University) · PhD Public Policy (UMass Boston) · FACMPE. Not MD — credential correction; he is PhD.
Pre-AMA: UMass Medical School (Family Medicine & Community Health, assistant-professor appointment) + BCG health care practice. Signed MSA AMA 24377 + SOW 17 on AMA’s behalf. Named in §16.2 as AMA’s executive of record for dispute escalation. Email: michael.tutty@ama-assn.org.
PROMOTED from VP to GVP. Prior: inaugural Chief Well-Being Officer at both MUSC and ChristianaCare; launched one of the nation’s first physician peer-support programs. MHCDS (Dartmouth) + emergency medicine background.
Her PS2 portfolio: leads Joy in Medicine® Recognition Program and Organizational Biopsy® — the AMA’s survey-side institutional burnout assessment tools. Both are survey-first instruments, adjacent/competing with FHG’s exhaust-first ClinicianPulse.
Nancy’s read (June 20): “a lot of challenge in front of her and how she’s gonna navigate that.” Navigating the Atalan/Fogg pressure in her own unit + the CAC integration headwinds.
| Line Item | Scope | Amount |
|---|---|---|
| Hosting | DataLab + Clinician.Health infrastructure | $351,200 |
| Application Management | Ongoing platform management | $298,800 |
| Enhancements | Development + feature work | $194,200 |
| Sandbox | Dev/test environment | $7,800 |
| SOW 6 TCV (NTE) | $852,000 | |
Effective: Jan 1, 2026 · Term: through Dec 31, 2026. Named FHG personnel: Barbouche (CEO) · Brendemuehl (VP Data & Analytics) · Kittleson (Channel Dir) · Lopez Thong (PM).
The IP architecture (the operative line at renewal): AMA owns the DataLab data (raw + transformed + calculated + aggregated + derived). FHG owns the software code that does the transformations. This is also the protection against Atalan CRI — Atalan has no contractual anchor inside the DataLab.
John Whyte eliminated CHE (Center for Health Equity) as a standalone Mission BU and merged it with IHO (Improving Health Outcomes) into the new Center for Optimal Health Outcomes (COHO). The IHO BP Initiative SLA documents in our contract archive are now housed here.
Four COHO pillars: (1) Social Determinants of Health · (2) Medical Education · (3) Community-Centered Solutions · (4) Data-Driven Approaches & Research.
COHO programs: Release the Pressure (AMA MAP BP™ hypertension control) · Medical Justice in Advocacy Fellowship × Morehouse SHLI · Advancing Equity through Quality & Safety Peer Network × Brigham + Joint Commission · West Side United · In Full Health · Rise to Health Coalition.
Elevated from GVP IHO + VP Performance & Operations to Interim Lead, Center for Optimal Health Outcomes — running the consolidated CHE + IHO unit. One week after the May 10 Organimi screengrab, she was running the entire consolidated Mission BU in interim capacity. The fastest and most surprising elevation in the Whyte-era restructuring.
Any FHG outcomes / equity / population / BP-control work formerly split between CHE and IHO now routes through Seoh as the COHO named seat. SOW 7 ($480K quarterly hosting) + SOW 8 ($250K support + enhancements) are in her operational lane.
| SOW | Scope | Payment Cadence | TCV |
|---|---|---|---|
| SOW 7 · eff Feb 27, 2026 | Production hosting | 4 × $120K quarterly (Mar 2 / Jun 1 / Sep 1 / Dec 1) | $480,000 |
| SOW 8 · eff Feb 27, 2026 | Platform support $50K + metric updates $50K + 3 front-end enhancements × $50K | Milestone-based | $250,000 |
| COHO Combined TCV (2026) | $730,000 | ||
Who he is: 178th AMA President (2023–2024). MCW Senior Associate Dean for Research. AHW Endowment Director (the direct AHW connection). Health2047 Board of Directors — AMA’s venture/innovation subsidiary (Lawrence K. Cohen is CEO); Ehrenfeld’s board seat anchors the AMA × FHG connection at the corporate-governance layer. Navy Commander. Milwaukee VA patient.
What he does for FHG:
Who she is: 173rd AMA President (2018–2019). CEO, New Mexico Cancer Center (NMCC). AMA Foundation Board. Community oncologist. COME HOME trial (Community Oncology Medical Home) → CMS OCM (Oncology Care Model) lineage — Barbara took a community-oncology payment innovation into a federal CMS model. She has done it before.
Why she matters for FHG: Barbara is in the room where the HCSC × BCBSNM × ONCare × SOLV × FHG thesis lives. Per Michael (2026-05-02): “ONCare is the power.” Field-of-Dreams thesis anchor. She is co-defining the economic mechanism FHG is operationalizing.
MASON 3.0 — what Barbara confirmed: The Three-Payment Model for oncology. FFS + Prospective + Risk Sharing — Barbara confirmed this architecture. NMOHC (New Mexico Oncology Hematology Consultants) + NMCC = the Pilot site. This is the SOLV CRG / Three-Payment architecture applied to oncology with a named community-oncology network as the live test site.
~/Claude/HCSC/HCSC/MEMORY.mdFrom garbled audio — confirm with Michael today before using:
Nancy’s June 20 read: 2-year extension is AMA’s apparent preference. Is that the shape Tutty / Farley / Whyte actually want to propose? What are FHG’s commercial terms to attach — TCV increase? Expanded SOW scope?
Jane Fogg’s formal relationship to Atalan (champion / advisor / buyer) is Michael’s intel, not yet publicly confirmed. Confirm today before FHG makes any competitive move inside AMA. Who else at AMA knows?
Nancy is overjoyed with ClinicianPulse and interested in applying it at Cleveland. Does she have an active Cleveland Clinic relationship? What’s the right next step before she retires?
Sabotage / sniffed out · Rotenstein · someone “ready to be done” · Nathan · CSF — what do these refer to?
New AMA President-elect. Does Fryhofer carry any of our threads (Barbara McAneny / Nankivil / Tutty-Seoh-Ehrenfeld / SOLV-CRG / Three-Payment)? Nothing in the brain yet. Michael’s color first.
New COO is Fresenius / DaVita-adjacent nephrologist. Nancy flagged this directly. Does Michael know him from Clinical Network work? AMA-side picture is “very murky” — hold loosely until confirmed.
The #1 administrative action for the engagement before year-end. Does Tutty know the replacement? Can FHG propose a name? This must be resolved before the renewal is signed.
Get Tutty on the record re: 2-year extension preference. Begin the commercial-terms conversation. Identify who drafts the renewal (Loebach’s office? Tutty directly?).
Identify Nankivil’s replacement. Execute the name change before or contemporaneous with the renewal. Don’t let this slip to November.
Surface exhaust-first vs. survey-first differentiation to Tutty. ClinicianPulse is already embedded in the DataLab. §7.5 IP architecture + §3.5 bilateral clause are the protections. Consider sharpening §3.5 at renewal.
If Nancy has an active Cleveland Clinic relationship, identify the right door. A targeted ClinicianPulse leave-behind, Nancy-tagged, could travel that thread independently of the AMA renewal. Move before she retires.
Tutty is the bridge. A brief warm intro now beats a cold signature conversation in November. Ask Tutty to broker a 15-minute call or in-person meet.
No prior FHG thread. Dedicated dossier pass — specialty, career arc, prior AMA service, board seats, any tie to our strategic spine. Michael’s color first; then a research pass.